Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes.

The PTPN1 gene codes for protein tyrosine phosphatase 1B (PTP1B) (EC 3.1.3.48), which negatively regulates insulin signaling by dephosphorylating the phosphotyrosine residues of the insulin receptor kinase activation segment. PTPN1 is located in 20q13, a genomic region linked to type 2 diabetes in multiple genetic studies. Surveys of the gene have previously identified only a few uncommon coding single nucleotide polymorphisms (SNPs). We have carried out a detailed association analysis of 23 noncoding SNPs spanning the 161-kb genomic region, which includes the PTPN1 gene. These SNPs have been assessed for association with type 2 diabetes in two independently ascertained collections of Caucasian subjects with type 2 diabetes and two control groups. Association is observed between multiple SNPs and type 2 diabetes. The most consistent evidence for association occurred with SNPs spanning the 3' end of intron 1 of PTPN1 through intron 8 (P values ranging from 0.043 to 0.004 in one case-control set and 0.038-0.002 in a second case-control set). Analysis of the combined case-control data increased the evidence of SNP association with type 2 diabetes (P = 0.005-0.0016). All of the associated SNPs lie in a single 100-kb haplotype block that encompasses the PTPN1 gene. Analysis of haplotypes indicates a significant difference between haplotype frequencies in type 2 diabetes case and control subjects (P = 0.0035-0.0056), with one common haplotype (36%) contributing strongly to the evidence for association with type 2 diabetes. Odds ratios calculated from single SNP or haplotype data are in the proximity of 1.3. Haplotype-based calculation of population-attributable risk (PAR) results in an estimated PAR of 17-20% based on different models and assumptions. These results suggest that PTPN1 is a significant contributor to type 2 diabetes susceptibility in the Caucasian population. This risk is likely due to noncoding polymorphisms.

[1]  C. Langefeld,et al.  Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster. , 2003, Genomics.

[2]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Steuart Rorke,et al.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness , 2002, Nature.

[4]  C. Langefeld,et al.  Heritability of Carotid Artery Intima-Medial Thickness in Type 2 Diabetes , 2002, Stroke.

[5]  P. Almgren,et al.  A variation in 3' UTR of hPTP1B increases specific gene expression and associates with insulin resistance. , 2002, American journal of human genetics.

[6]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[7]  B. Zinman,et al.  A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree. , 2002, The Journal of clinical endocrinology and metabolism.

[8]  T. Hansen,et al.  A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. , 2002, Diabetes.

[9]  Sinead B. O'Leary,et al.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.

[10]  P. Dawson,et al.  Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. , 2001, Molecular genetics and metabolism.

[11]  S. Rich,et al.  A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20. , 2001, Genomics.

[12]  C. Langefeld,et al.  Familial aggregation of coronary artery calcium in families with type 2 diabetes. , 2001, Diabetes.

[13]  S. Lewitzky,et al.  A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. , 2001, Diabetes.

[14]  Y. Boie,et al.  Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes. , 2000, Gene.

[15]  C. Langefeld,et al.  Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. , 2000, Diabetes.

[16]  D. Bowden,et al.  Identification and characterization of PRKCBP1, a candidate RACK-like protein , 2000, Mammalian Genome.

[17]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[18]  D. Bowden,et al.  Analysis of the HNF4α gene in Caucasian Type II diabetic nephropathic patients , 2000, Diabetologia.

[19]  M. White,et al.  Tyrosine Dephosphorylation and Deactivation of Insulin Receptor Substrate-1 by Protein-tyrosine Phosphatase 1B , 2000, The Journal of Biological Chemistry.

[20]  Gonçalo R. Abecasis,et al.  GOLD-Graphical Overview of Linkage Disequilibrium , 2000, Bioinform..

[21]  D. Bowden,et al.  A physical map of the 20q12-q13.1 region associated with type 2 diabetes. , 1999, Genomics.

[22]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[23]  S. Rich,et al.  Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. , 1998, Hypertension.

[24]  J. Beckmann,et al.  A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. , 1997, Human molecular genetics.

[25]  S. Rich,et al.  Linkage of Genetic Markers on Human Chromosomes 20 and 12 to NIDDM in Caucasian Sib Pairs With a History of Diabetic Nephropathy , 1997, Diabetes.

[26]  S. Rich,et al.  New Susceptibility Locus for NIDDM Is Localized to Human Chromosome 20q , 1997, Diabetes.

[27]  J. Olefsky,et al.  Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor , 1996, Diabetes.

[28]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.